NCT01527344View on ClinicalTrials.gov

Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Cardiac Allograft Vasculopathy
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Mayo Clinic

OTHER

NCT01527344 - Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography | Biotech Hunter | Biotech Hunter